Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.85 CHF
−49.98 M CHF
311.26 M CHF
13.27 M
About POLYPEPTIDE N
Sector
Industry
CEO
Juan-José Gonzalez
Website
Headquarters
Baar
Founded
1996
ISIN
CH1110760852
FIGI
BBG0100P02R8
PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1996 and is headquartered in Zug, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PPGN is 28.90 CHF — it has increased by 1.05% in the past 24 hours. Watch POLYPEPTIDE N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange POLYPEPTIDE N stocks are traded under the ticker PPGN.
PPGN stock has fallen by −2.03% compared to the previous week, the month change is a 4.90% rise, over the last year POLYPEPTIDE N has showed a 63.09% increase.
We've gathered analysts' opinions on POLYPEPTIDE N future price: according to them, PPGN price has a max estimate of 44.98 CHF and a min estimate of 33.49 CHF. Watch PPGN chart and read a more detailed POLYPEPTIDE N stock forecast: see what analysts think of POLYPEPTIDE N and suggest that you do with its stocks.
PPGN reached its all-time high on Sep 6, 2021 with the price of 147.40 CHF, and its all-time low was 14.10 CHF and was reached on Jan 22, 2024. View more price dynamics on PPGN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PPGN stock is 2.96% volatile and has beta coefficient of 1.42. Track POLYPEPTIDE N stock price on the chart and check out the list of the most volatile stocks — is POLYPEPTIDE N there?
Today POLYPEPTIDE N has the market capitalization of 953.23 M, it has decreased by −1.38% over the last week.
Yes, you can track POLYPEPTIDE N financials in yearly and quarterly reports right on TradingView.
POLYPEPTIDE N is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
PPGN earnings for the last half-year are −0.34 CHF per share, whereas the estimation was −0.68 CHF, resulting in a 50.70% surprise. The estimated earnings for the next half-year are 0.06 CHF per share. See more details about POLYPEPTIDE N earnings.
POLYPEPTIDE N revenue for the last half-year amounts to 130.00 M CHF, despite the estimated figure of 129.15 M CHF. In the next half-year revenue is expected to reach 197.73 M CHF.
PPGN net income for the last half-year is −10.95 M CHF, while the previous report showed −16.45 M CHF of net income which accounts for 33.43% change. Track more POLYPEPTIDE N financial stats to get the full picture.
As of Dec 29, 2024, the company has 1.27 K employees. See our rating of the largest employees — is POLYPEPTIDE N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. POLYPEPTIDE N EBITDA is 12.01 M CHF, and current EBITDA margin is −3.27%. See more stats in POLYPEPTIDE N financial statements.
Like other stocks, PPGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade POLYPEPTIDE N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So POLYPEPTIDE N technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating POLYPEPTIDE N stock shows the neutral signal. See more of POLYPEPTIDE N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.